Showing 1 - 4 results of 4 for search 'Kevin Biteau', query time: 0.02s Refine Results
  1. 1
    TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment

    TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment by Régis Brion, Malika Gantier, Kevin Biteau, Julien Taurelle, Bénédicte Brounais-Le Royer, Franck Verrecchia, Françoise Rédini, Romain Guiho

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction.

    Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. by Eva Mathieu, Guillaume Lamirault, Claire Toquet, Pierre Lhommet, Emilie Rederstorff, Sophie Sourice, Kevin Biteau, Philippe Hulin, Virginie Forest, Pierre Weiss, Jérôme Guicheux, Patricia Lemarchand

    Published 2012-01-01
    Get full text
    Article
  3. 3
    ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells

    ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells by Geoffroy Danieau, Sarah Morice, Sarah Renault, Régis Brion, Kevin Biteau, Jérôme Amiaud, Marie Cadé, Dominique Heymann, Frédéric Lézot, Franck Verrecchia, Françoise Rédini, Bénédicte Brounais-Le Royer

    Published 2021-05-01
    Get full text
    Article
  4. 4
    493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanized preclinical models

    493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanize... by Vanessa Gauttier, Marion Drouin, Caroline Mary, Géraldine Teppaz, Ariane Desselle, Virginie Thépénier, Emmanuelle Wilhelm, Elise Chiffoleau, Nicolas Poirier, Isabelle Girault, Cecile Batty, Marine Malloci, Julien Taurelle, Irène Baccelli, Stéphanie Neyton, Mylène Deramé, Kevin Biteau, Marion Colonello

    Published 2023-11-01
    Article

Search Tools: